Document:

Document

Exhibit 10.2

CERTAIN INFORMATION IDENTIFIED BY “[***]” HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

						
	
	

May 4, 2021 

Re: Collaboration License Agreement by and between MYOVANT SCIENCES GMBH (“Myovant”) and PFIZER INC. (“Pfizer”), dated as December 26, 2020 (the “Myovant/Pfizer Agreement”) 
This side letter agreement (the “Side Letter Agreement”) relates to the Myovant/Pfizer Agreement, under which Myovant and Pfizer have agreed for Pfizer to have an exclusive option to obtain exclusive commercialization and promotion rights and related development rights for the Oncology Product(s) in the Oncology Field in the Pfizer Territory (each as defined therein), among other activities, in accordance with the terms of the Myovant/Pfizer Agreement.  The Parties now wish to enter into this Side Letter Agreement to extend the time period within which Pfizer may exercise such exclusive option under Section 10.5 of the Agreement. 
Unless otherwise noted, capitalized terms used, but not defined herein, shall have the respective meanings ascribed to them in the Myovant/Pfizer Agreement, as the context requires. 
Myovant and Pfizer hereby agree as follows: 
1.Section 1.185 is hereby deleted in its entirety and replaced as follows: 
“Option Period” means the time period beginning on the date when a Drug Approval Application is filed with the EMA with respect to the Oncology Product for prostate cancer and ending on [***]. 
2.Termination.  This Side Letter Agreement shall terminate automatically upon any expiration or termination of the Myovant/Pfizer Agreement in its entirety. 
3.Miscellaneous.  The provisions of Sections 18.7 (Amendment), 18.8 (Notices), 18.11 (Severability), 18.12 (Waivers) and 18.15 (Counterparts) of the Myovant/Pfizer Agreement are hereby incorporated by reference as though set out in full in this Side Letter Agreement, provided that each reference to “this Agreement” in such incorporated provisions shall be construed as a reference to this Side Letter Agreement. 
4.Entire Agreement.  This Side Letter Agreement and the Myovant/Pfizer Agreement set forth and constitute the entire agreement and understanding between the Parties with respect to the subject matter hereof and all prior agreements, understandings, promises, and representations, whether written or oral, with respect thereto are superseded hereby and thereby. 

5.Governing Law.  This Agreement shall be governed by and construed and enforced under the substantive laws of the State of New York, without giving effect to any choice of law rules that might otherwise refer construction or interpretation of this Agreement to the substantive law of another jurisdiction.  The United Nations Convention on Contracts for the International Sale of Goods (1980) shall not apply to this Agreement. 
6.Disputes.  Any controversy or claim arising out of or relating to this Side Letter Agreement shall constitute a “Dispute” under the Myovant/Pfizer Agreement, and Section 17.2 of the Myovant/Pfizer Agreement shall apply to any such Dispute accordingly. 

[Signature page follows]

This Side Letter Agreement is signed below by authorized representatives of Myovant and Pfizer, respectively indicating the Parties’ acceptance of the terms and conditions of this Side Letter Agreement.

												
	MYOVANT SCIENCES GMBH	PFIZER INC.
	By:	/s/ Elke Hunsche	By:	/s/ John DeYoung
	Name:	Elke Hunsche	Name:	John DeYoung
	Title:	VP, Global Market Access & HEOR	Title:	Vice President

[SIGNATURE PAGE FOR SIDE LETTER AGREEMENT]Document

Exhibit 4.1

Volume Submitter (Modified) Legislative Amendment Final Hardship Law Changes
466998
This document was signed according to the records of the Principal Life Insurance Company. The "This Document Was Electronically Signed By" heading displays the name of the person that electronically signed the document along with the date the electronic signature was received. Changes to your documents become effective the latter of the Effective Date or the Signed Date, unless an earlier date is required by law.
The electronic signature(s) received by the Principal Life Insurance Company (Principal Life) are in compliance with the electronic signature procedures established by Principal Life.

Jim Harbour
Defined Contribution Document Leader
Principal Life Insurance Company

   This Document was Electronically
   Signed By:

    LAURA KUROWSKI
    04/28/2021
    12:54 PM

AMENDMENT TO COMPLY WITH
THE BIPARTISAN BUDGET ACT OF 2018

This amendment of the Plan is adopted to comply with the requirements of certain provisions of the Bipartisan Budget Act of 2018 and final regulations that amend the rules relating to hardship distributions.  This amendment is to be construed in accordance with such laws and any applicable regulations.  This amendment shall continue to apply to the Plan, including the Plan as later amended, until such provisions are integrated into the Plan or the provisions of this amendment are specifically amended.
This amendment shall supersede any previous amendment and the provisions of the Plan to the extent those provisions are inconsistent with the provisions of this amendment.
Plan Name:     Independent Financial 401(k) Profit Sharing Plan 
The Plan named above gives the undersigned the right to amend it at any time. According to that right, the Plan is amended as follows:
CHANGES TO FINANCIAL HARDSHIP WITHDRAWALS
The provisions of this section of the amendment shall be effective April 10, 2021, in accordance with the Bipartisan Budget Act of 2018.
Subparagraph (b) in the WHEN BENEFITS START SECTION of Article V is amended by striking the subparagraph and substituting the following:
(b)    The Participant’s  Vested Account resulting from Elective  Deferral  Contributions, Qualified Nonelective Contributions, Qualified Matching Contributions, QACA Matching Contributions, and QACA Nonelective Contributions may not be distributed earlier than Severance from Employment, death, or disability. However, such amount may be distributed upon:
(1)    Termination of the Plan as permitted in Article VIII. 
(2)    The attainment of age 59 1/2 if such distribution is permitted in the WITHDRAWAL BENEFITS SECTION of this article.
(3)    The attainment of Normal Retirement Age, provided such age is at least age 59 1/2 and such distribution is permitted in the definition of Normal Retirement Date in the DEFINITIONS SECTION of Article I.
(4)    A federally declared disaster, where resulting legislation authorizes such a distribution. 
(5)    Satisfying the requirements for a hardship withdrawal, if such distribution is permitted in the WITHDRAWAL BENEFITS SECTION of this article.
The Participant’s Vested Account resulting from Elective Deferral Contributions may also be distributed:
(6)    As a Qualified Reservist Distribution, if such distribution is permitted in the WITHDRAWAL BENEFITS SECTION of this article.
(7)    If the Participant is deemed to have had a severance from employment as described in Code Section 414(u)(12)(B)(i), if such distribution is permitted in the VESTED BENEFITS SECTION of this article.
Subtype 101006    2    Plan ID No. 1063569 (4-66998)

The Financial Hardship Withdrawal portion in the WITHDRAWAL BENEFITS SECTION of Article V is amended by striking the first paragraph and substituting the following:
Financial Hardship Withdrawal. A Participant may withdraw any part of his Vested Account resulting from Elective Deferral Contributions in the event of hardship due to an immediate and heavy financial need.
The Financial Hardship Withdrawal portion in the WITHDRAWAL BENEFITS SECTION of Article V is amended by adding the following contributions to the second paragraph:
Qualified Matching Contributions
Wage Rate Contributions that are designated as Qualified Nonelective Contributions
QACA Matching Contributions 
Qualified Nonelective Contributions 
QACA Nonelective Contributions
The paragraph regarding the list of immediate and heavy financial needs used for purposes of hardship withdrawals in the WITHDRAWAL BENEFITS SECTION of Article V is amended by striking that paragraph (other than the Option to allow withdrawal for primary beneficiary) and substituting the following:
Immediate and heavy financial need shall be limited to:  (i) expenses incurred or necessary for medical care that would be deductible under Code Section 213(a) (determined without regard to whether the expenses exceed the stated limit on adjusted gross income); (ii) the purchase (excluding mortgage payments) of a principal residence for the Participant; (iii) payment of tuition, related educational fees, and room and board expenses, for up to the next 12 months of postsecondary education for the Participant, his spouse, children, or dependents (as defined in Code Section 152 without regard to Code Sections 152(b)(1), (b)(2), and (d)(1)(B)); (iv) payments necessary to prevent the eviction of the Participant from, or foreclosure on the mortgage of, the Participant’s principal residence; (v) payments for funeral or burial expenses for the Participant’s deceased parent, spouse, child, or dependent (as defined in Code Section 152 without regard to Code Section 152(d)(1)(B)); (vi) expenses to repair damage to the Participant’s principal residence that would qualify for a casualty loss deduction under Code Section 165 (determined without regard to Code Section 165(h)(5) and whether the loss exceeds 10% of adjusted gross income); (vii) expenses and losses (including loss of income) incurred by the Employee on account of a disaster declared by the Federal Emergency Management Agency (FEMA) under the Robert T. Stafford Disaster Relief and Emergency Assistance Act, Public Law 100-707, provided that the Employee’s principal residence or principal place of employment at the time of the disaster was located in an area designated by FEMA for individual assistance with respect to the disaster; or (viii) any other distribution which is deemed by the Commissioner of Internal Revenue to be made on account of immediate and heavy financial need as provided in Treasury regulations.
The deemed necessary rule in the Financial Hardship Withdrawal portion in the WITHDRAWAL BENEFITS SECTION of Article V is amended by striking the last two paragraphs and substituting the following:
Such withdrawal shall be deemed necessary only if all of the following requirements are met: (i) the Participant cannot relieve the immediate and heavy financial need from cash or other liquid resources that are reasonably available to the Participant, (ii) the distribution is not in excess of the amount of the immediate and heavy financial need (including amounts necessary to pay any Federal, state, or local income taxes or penalties reasonably anticipated to result from the distribution), and (iii) the Participant has obtained all distributions, other than hardship distributions, currently available under all plans maintained by the Employer.
Subtype 101006    3    Plan ID No. 1063569 (4-66998)

In determining whether the immediate and heavy financial need can be relieved from cash or other liquid resources that are reasonably available to a Participant, the Employer may rely on the Participant's representation (unless the Employer has actual knowledge to the contrary) that the need cannot reasonably be relieved from other resources.
Any elective contributions or participant contributions, under this Plan or any other plans maintained by the Employer, that had been suspended due to a prior hardship withdrawal shall resume as of January 1, 2020.
This amendment is made an integral part of the aforesaid Plan and is controlling over the terms of said Plan with respect to the particular items addressed expressly herein.  All other provisions of the Plan remain unchanged and controlling.
Unless otherwise stated on any page of this amendment, eligibility for benefits and the amount of any benefits payable to or on behalf of an individual who is an Inactive Participant on the effective date(s) stated above, shall be determined according to the provisions of the aforesaid Plan as in effect on the day before he became an Inactive Participant.
Signing this amendment, the Employer, as plan sponsor, has made the decision to adopt this plan amendment. The Employer is acting in reliance on its own discretion and on the legal and tax advice of its own advisors, and not that of any member of the Principal Financial Group or any representative of a member company of the Principal Financial Group.

Signed this      day of     
By         
Title         
Subtype 101006    4    Plan ID No. 1063569 (4-66998)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00331-of-00352.parquet"}]]